Finance

Lists
Q3 2026 earnings • released • EPS miss -81,97% • Revenue miss -0,27%
See results
HIMS:NYSE
Hims & Hers Health Inc
19,73 USD
+0,05%
(+0,010) 1D
19,41 USD
-1,61% (-0,32)
After hours
Closed: 13-ноя., 16:00:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HIMS...
Open
19,68 USD
High
20,16 USD
Low
19,18 USD
Mkt. cap
4,62 млд
Avg. vol.
13,79 млн
Volume
10,07 млн
52-wk high
40,99 USD
52-wk low
13,74 USD
EPS
-0,83 USD
Beta
2,53
Shares outstanding
224,94 млн
No. of employees
2 миң
Open
19,68 USD
High
20,16 USD
Low
19,18 USD
Mkt. cap
4,62 млд
Avg. vol.
13,79 млн
Volume
10,07 млн
52-wk high
40,99 USD
52-wk low
13,74 USD
EPS
-0,83 USD
Beta
2,53
Shares outstanding
224,94 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2,44 миң
Foundedноя. 2017
HeadquartersСан Франциско, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryHealth care provider
Website-
Analyst ratings
Based on 12 analysts giving stock ratings to HIMS in the past 3 months
Hold
Buy
3
Hold
9
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for HIMS in the last 3 months.
Highest
Current 19,73 USD
40,00 USD (+102,74%)
Average
29,22 USD (+48,10%)
Lowest
24,00 USD (+21,64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Patterson
KeyBanc
Hold
Maintained
-
-
11/11/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
-
-
11/10/2026
Michael Cherny
Leerink Partners
Hold
Maintained
24,00 USD
+21,6%
11/10/2026
Bryan Smilek
J.P. Morgan
Hold
Maintained
24,00 USD
+21,6%
11/10/2026
Mark Mahaney
Evercore ISI
Hold
Maintained
27,00 USD
+36,8%
11/10/2026
Brian Tanquilut
Jefferies
Hold
Maintained
24,00 USD
+21,6%
11/10/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
25,00 USD
+26,7%
11/10/2026
Ryan MacDonald
Needham
Buy
Reiterated
32,00 USD
+62,2%
11/10/2026
Maria Ripps
Canaccord Genuity
Buy
Maintained
40,00 USD
+102,7%
11/10/2026
David Larsen
BTIG
Hold
Maintained
-
-
11/09/2026
Glen Santangelo
Barclays
Buy
Maintained
35,00 USD
+77,4%
11/10/2026
Jailendra Singh
Truist Financial
Hold
Reiterated
32,00 USD
+62,2%
09/11/2026
George Hill
Deutsche Bank
Hold
Reiterated
26,00 USD
+31,8%
08/11/2026
Jonna Kim
TD Cowen
Hold
Reiterated
30,00 USD
+52,1%
08/11/2026
Daniel Grosslight
Citi
Hold
Maintained
33,00 USD
+67,3%
08/12/2026
Oliver Chen
TD Cowen
Hold
Reiterated
25,00 USD
+26,7%
05/12/2026
Cory Carpenter
J.P. Morgan
Buy
Maintained
33,00 USD
+67,3%
05/12/2026
Unknown Analyst
Nephron
Buy
Upgraded
35,00 USD
+77,4%
03/09/2026
Last report
2026-ж., 10-ноя.
Fiscal period
Q3 2026
0,03 USD / 0,15 USD
-81,97%miss
Revenue / Est. (USD)
890,37 млн / 892,77 млн
-0,27%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
617,82 млн
608,10 млн
753,21 млн
890,37 млн
Cost of goods sold
173,38 млн
182,82 млн
272,41 млн
381,17 млн
Cost of revenue
173,38 млн
182,82 млн
272,41 млн
381,17 млн
Research and development expenses
40,96 млн
46,94 млн
54,90 млн
69,39 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
386,64 млн
426,37 млн
521,95 млн
505,96 млн
Operating expense
427,60 млн
473,31 млн
576,85 млн
575,34 млн
Total operating expenses
600,99 млн
656,13 млн
849,26 млн
956,52 млн
Operating income
16,83 млн
-48,02 млн
-96,04 млн
-66,15 млн
Other non operating income
1,82 млн
-18,58 млн
-2,43 млн
-514,00 миң
EBT including unusual items
18,35 млн
-101,55 млн
-92,63 млн
-46,25 млн
EBT excluding unusual items
21,56 млн
-61,57 млн
-96,22 млн
-67,36 млн
Income tax expense
-2,25 млн
-9,44 млн
-6,34 млн
-13,21 млн
Effective tax rate
-12,25%
9,29%
6,85%
28,56%
Other operating expenses
-
-
-
-
Net income
20,60 млн
-92,12 млн
-86,29 млн
-33,04 млн
Net profit margin
3,33%
-15,15%
-11,46%
-3,71%
Earnings per share
0,22
-0,19
-0,09
0,03
Interest and investment income
3,83 млн
7,90 млн
6,00 млн
4,80 млн
Interest expense
-921,00 миң
-2,87 млн
-3,75 млн
-5,50 млн
Net interest expenses
2,90 млн
5,03 млн
2,25 млн
-702,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
34,92 млн
-26,07 млн
-66,57 млн
-27,94 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору